Month: October 2024

Nitrosamine Impurities in Pharmaceuticals: Challenges and Solutions

Nitrosamine Impurities in Pharmaceuticals: Challenges and Solutions

This article describes nitrosamine impurities in pharmaceuticals, their formation in the process, and their control strategies with case studies, and FAQs.

Impurities Control Strategies In Pharmaceuticals: Why & How

Impurities Control Strategies In Pharmaceuticals: Why & How

Impurities Control Strategies In Pharmaceuticals: Why & How Introduction and outcome: Impurities Control Strategies Impurities Control Strategies play a unique...

Chromatographic Peak Integration: How to Avoid Common Error

Chromatographic Peak Integration: How to Avoid Common Error

This article describes chromatographic peak integration, its types, interrelation errors and their source, and approaches to avoid integration errors with FAQs

Forced Degradation Studies in Pharmaceuticals: How to Perform

Forced Degradation Studies in Pharmaceuticals: How to Perform

Forced degradation studies reveal the intrinsic stability of pharmaceuticals, degradation pathways, and stability indicator strength of the analytical method.

You cannot copy content of this page

×